3M Currently Up Seven Consecutive Days, On Pace for Longest Winning Streak Since March 2022 — Data Talk
3M Company (MMM) is currently at $105.02, up $3.78 or 3.73%
--Would be highest close since Jan. 17, 2023, when it closed at $105.85
--On pace for largest percent increase since April 30, 2024, when it rose 4.72%
--Currently up seven consecutive days; up 9.92% over this period
--Longest winning streak since March 22, 2022, when it rose for seven straight trading days
--Best seven day stretch since the seven days ending March 20, 2024, when it rose 14.95%
--Up 8.82% month-to-date
--Up 14.9% year-to-date
--Down 51.43% from its all-time closing high of $216.23 on Jan. 26, 2018
--Up 26.06% from 52 weeks ago (May 18, 2023), when it closed at $83.31
--Would be a new 52-week closing high
--Up 46.74% from its 52-week closing low of $71.57 on Oct. 23, 2023
--Traded as high as $105.16; highest intraday level since Jan. 18, 2023, when it hit $106.34
--Up 3.87% at today's intraday high; largest intraday percent increase since April 30, 2024, when it rose as much as 6.16%
--Second best performer in the DJIA today
--Third best performer in the S&P 500 today
--Contributed 24.83 points to the DJIA so far today
All data as of 11:13:57 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 16, 2024 11:33 ET (15:33 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks